Alternaria-induced asthma

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 2, 2004, Pages 227-234

  Bush, Robert K ^a   Prochnau, Jay J ^b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b NONE

Author keywords

Aerobiology; Allergens; Alternaria; Asthma

Indexed keywords

ALLERGEN; BRONCHODILATING AGENT; FLUTICASONE; IMMUNOGLOBULIN E; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; PREDNISONE; SALBUTAMOL; SALMETEROL;

ACUTE DISEASE; AEROSPACE MEDICINE; ALTERNARIA; ANAMNESIS; ARTICLE; ASTHMA; CASE REPORT; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNOLOGY; INDOOR AIR POLLUTION; INHALATIONAL DRUG ADMINISTRATION; LABORATORY TEST; MALE; MICROBIOLOGY; NEBULIZATION; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SEASON; SKIN TEST; TREATMENT OUTCOME;

EID: 1142285225     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.11.023     Document Type: Article

References (51)

1. O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359-63.
2. Werner HA. Status asthmaticus in children: a review. Chest 2001;119:1913-29.
3. Busse WW, O'Bryne PM, Holgate ST. Asthma pathogenesis. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, editors. Middleton's allergy: principles and practice. Philadelphia: Mosby; 2003. p. 1175-207.
4. Jarjour NN. Asthma in adults: evaluation and management. In: Adkinson NF, YungingerJW, Busse WW, Bochner BS, Holgate ST, Simons FER, editors. Middleton's allergy: principles and practice. Philadelphia: Mosby; 2003. p. 1257-81.
5. Seear M, Hui H, Magee F, Bohn D, Cutz E. Bronchial casts in children: a proposed classification based on nine cases and a review of the literature. Am J Respir Crit Care Med 1997;155:364-70.
6. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002;169:5904-11.
7. Hewitt CR, Brown AP, Hart BJ, Pritchard DI. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 1995;182:1537-44.
8. Wan GH, Li CS, Guo SP, Rylander R, Lin RH. An airbone mold-derived product, beta-1,3-D-glucan, potentiates airway allergic responses. Eur J Immunol 1999;29:2491-7.
9. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105:1185-93.
10. Kenyon N, Albertson TE. Status asthmaticus: from the emergency department to the intensive care unit. Clin Rev Allergy Immunol 2001;20:271-92.
11. Bush RK, Portnoy JM. The role and abatement of fungal allergens in allergic diseases. J Allergy Clin Immunol 2001;107:S430-40.
12. Bush RK. The role of fungal allergens: assessment and control. In: Bush RK, editor. Environmental asthma. New York: Marcel Dekker; 2001. p. 69-90.
13. Cantani A, Businco E, Maglio A. Alternaria allergy: a three-year controlled study in children treated with immunotherapy. Allergol Immunopathol (Madr) 1988;16:1-4.
14. Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Altemaria extract. J Allergy Clin Immunol 1990;85:460-72.
15. Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 1996;6:55-62.
16. Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-21.
17. Addroth E, Rak S, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000;106:253-9.
18. Milgrom H, Pick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody: rhuMAb-E25 Study Group. N Engl J Med 1999;341:1966-73.
19. Soler M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18:254-61.
20. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-90.
21. Bush RK. The use of anti-IgE in the treatment of allergic asthma. Med Clin North Am 2002;86:1113-29.
22. Esch RE, Bush RK. Aerobiology of outdoor allergens. In: Adkinson JF Jr, Yunginger JW, Busse W, Bochner BS, Holgate ST, Simons FER, editors. Middleton's allergy principles and practice. St Louis: Mosby; 2003. p. 539-55.
23. Hopkins JG, Benham RW, Kesten BM. Asthma due to a fungus Alternaria. JAMA 1930;94:6-10.
24. Vijay HM, Thaker AJ, Banerjee B, Kurup VP. Mold allergens. In: Lockey RF, Bukantz SC, editors. Allergens and allergen immunotherapy. New York: Marcel Dekker; 1999. p. 113-54.
25. Portnoy J, Brothers D, Pacheco F, Landuyt J, Barnes C. Monoclonal antibody-based assay for Alt al, a major Alternaria allergen. Ann Allergy Asthma Immunol 1998;81:59-64.
26. Barnes C, Schreiber K, Pacheco F, Landuyt J, Hu F, Portnoy J. Comparison of outdoor allergenic particles and allergen levels. Ann Allergy Asthma Immunol 2000;84:47-54.
27. Portnoy J, Pacheco F, Barnes C, Upadrashta B, Crenshaw R, Esch R. Selection of representative Alternaria strain groups on the basis of morphology, enzyme profile, and allergen content. J Allergy Clin Immunol 1993;91:773-82.
28. Bush RK, Sanchez H, Geisler D. Molecular cloning of a major Alternaria alternata allergen, rAlt a 2. J Allergy Clin Immunol 1999;104:665-71.
29. Breitenbach M, Simon B, Probst G, Oberkofler H, Ferreira F, Briza P, et al. Enolases are highly conserved fungal allergens. Int Arch Allergy Immunol 1997;113:114-7.
30. Achatz G, Oberkofler H, Lechenauer E, Simon B, Unger A, Kandler D, et al. Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol 1995;32:213-27.
31. Portnoy J, Olson I, Pacheco F, Barnes C. Affinity purification of a major Alternaria allergen using a monoclonal antibody. Ann Allergy 1990;65:109-14.
32. Floyer J, Violent asthma after visiting a wine cellar: a treatise on asthma. London: Innys and Parker; 1745.
33. Gergen PJ, Turkeltaub PC, Kovar MG. The prevalence of allergic skin test reactivity to eight common aeroallergens in the US population: results from the second National Health and Nutrition Examination Survey. J Allergy Clin Immunol 1987;80:669-79.
34. Lopez M, Salvaggio JE. Mold-sensitive asthma. Clin Rev Allergy 1985;3:183-96.
35. Eggleston PA, Rosenstreich D, Lynn H, Gergen P, Baker D, Kattan M. et al. Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol 1998;102:563-70.
36. D'Amato G, Chatzigeorgiou G, Corsico R, Gioulekas D, Jager L, Jager S, et al. Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy: a European multicenter study promoted by the Subcommittee on Aerobiology and Environmental Aspects of Inhalant Allergens of the European Academy of Allergology and Clinical Immunology. Allergy 1997;52:711-6.
37. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol 1992;90:579-88.
38. Peat JK, Tovey E, Mellis CM, Leeder SR, Woolcock AJ. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1993;23:812-20.
39. Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997;155:1356-61.
40. Henderson FW, Henry MM, Ivins SS, Morris R, Neebe EC, Leu SY, et al. Correlates of recurrent wheezing in school-age children: the physicians of Raleigh Pediatric Associates. Am J Respir Crit Care Med 1995;151:1786-93.
41. Perzanowski MS, Sporik R, Squillace SP, Gelber LE. Call R, Carter M, et al. Association of sensitization to Alternaria allergens with asthma among school-age children. J Allergy Clin Immunol 1998;101:626-32.
42. Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, Sternberg AL. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 1999;104:775-85.
43. Brace CA, Norman PS, Rosenthal RR, Lichtenstein LM. The role of ragweed pollen in autumnal asthma. J Allergy Clin Immunol 1977;59:449-59.
44. Delfino RJ, Coate BD, Zeiger RS, Seltzer JM, Street DH, Koutrakis P. Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am J Respir Crit Care Med 1996;154:633-41.
45. Nelson RP Jr, DiNicolo R, Fernandez-Caldas E, Seleznick MJ, Lockey RP, Good RA. Allergen-specific IgE levels and mite allergen exposure in children with acute asthma first seen in an emergency department and in nonasthmatic control subjects. J Allergy Clin Immunol 1996;98:258-63.
46. Dales RE, Cakmak S, Burnett RT, Judek S, Coates F, Brook JR. Influence of ambient fungal spores on emergency visits for asthma to a regional children's hospital. Am J Respir Crit Care Med 2000;162:2087-90.
47. Halonen M, Stern DA, Lohman C, Wright AL, Brown MA, Martinez FD. Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk. Am J Respir Crit Care Med 1999;160:564-70.
48. Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F. Is sensitization to Alternaria alternate a risk factor for severe asthma? a population-based study. J Allergy Clin Immunol 1999;103:709-11.
49. Downs SH, Mitakakis TZ, Marks GB, Car NG, Belousova EG, Leuppi JD, et al. Clinical importance of Alternaria exposure in children. Am J Respir Crit Care Med 2001;164:455-9.
50. Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995;95:955-61.
51. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000;55:501-4.